These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31526801)

  • 1. Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil.
    Mohammadkhani A; James MH; Pantazis CB; Aston-Jones G
    Brain Res; 2020 Mar; 1731():146461. PubMed ID: 31526801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil.
    Mohammadkhani A; Fragale JE; Pantazis CB; Bowrey HE; James MH; Aston-Jones G
    J Neurosci; 2019 Dec; 39(49):9831-9840. PubMed ID: 31641055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of orexin-1 receptor signaling in demand for the opioid fentanyl.
    Fragale JE; Pantazis CB; James MH; Aston-Jones G
    Neuropsychopharmacology; 2019 Sep; 44(10):1690-1697. PubMed ID: 31112988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual differences in orexin-I receptor modulation of motivation for the opioid remifentanil.
    Porter-Stransky KA; Bentzley BS; Aston-Jones G
    Addict Biol; 2017 Mar; 22(2):303-317. PubMed ID: 26598295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task.
    Wiskerke J; James MH; Aston-Jones G
    Brain Res; 2020 Mar; 1731():146222. PubMed ID: 31002819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.
    Moorman DE; James MH; Kilroy EA; Aston-Jones G
    Brain Res; 2017 Jan; 1654(Pt A):34-42. PubMed ID: 27771284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of orexin/hypocretin in conditioned sucrose-seeking in female rats.
    Cason AM; Aston-Jones G
    Neuropharmacology; 2014 Nov; 86():97-102. PubMed ID: 25036612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking.
    Smith RJ; See RE; Aston-Jones G
    Eur J Neurosci; 2009 Aug; 30(3):493-503. PubMed ID: 19656173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats.
    Zhou L; Smith RJ; Do PH; Aston-Jones G; See RE
    Neuropharmacology; 2012 Dec; 63(7):1201-7. PubMed ID: 22971541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent self-administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system.
    Fragale JE; James MH; Aston-Jones G
    Addict Biol; 2021 May; 26(3):e12946. PubMed ID: 32798290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin-1 receptor antagonist in rats.
    James MH; Bowrey HE; Stopper CM; Aston-Jones G
    Eur J Neurosci; 2019 Aug; 50(3):2602-2612. PubMed ID: 30240516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of orexin/hypocretin in conditioned sucrose-seeking in rats.
    Cason AM; Aston-Jones G
    Psychopharmacology (Berl); 2013 Mar; 226(1):155-65. PubMed ID: 23096770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lateral hypothalamus and orexinergic transmission in the paraventricular thalamus promote the attribution of incentive salience to reward-associated cues.
    Haight JL; Campus P; Maria-Rios CE; Johnson AM; Klumpner MS; Kuhn BN; Covelo IR; Morrow JD; Flagel SB
    Psychopharmacology (Berl); 2020 Dec; 237(12):3741-3758. PubMed ID: 32852601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of saccharin-seeking in rats by orexin/hypocretin receptor 1 antagonist.
    Cason AM; Aston-Jones G
    Psychopharmacology (Berl); 2013 Aug; 228(3):499-507. PubMed ID: 23494235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexin-1 receptor signaling increases motivation for cocaine-associated cues.
    Bentzley BS; Aston-Jones G
    Eur J Neurosci; 2015 May; 41(9):1149-56. PubMed ID: 25754681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective orexin 1 receptor antagonism does not affect effort-based responding for sucrose reward in rats.
    Bergamini G; Durkin S; Steiner MA
    J Psychopharmacol; 2024 Mar; 38(3):305-308. PubMed ID: 38327032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats.
    Nair SG; Golden SA; Shaham Y
    Br J Pharmacol; 2008 May; 154(2):406-16. PubMed ID: 18223663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats.
    Mahler SV; Smith RJ; Aston-Jones G
    Psychopharmacology (Berl); 2013 Apr; 226(4):687-98. PubMed ID: 22411428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the orexin/hypocretin system in ethanol conditioned place preference.
    Voorhees CM; Cunningham CL
    Psychopharmacology (Berl); 2011 Apr; 214(4):805-18. PubMed ID: 21107540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orexin / hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking.
    Smith RJ; Aston-Jones G
    Eur J Neurosci; 2012 Mar; 35(5):798-804. PubMed ID: 22356621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.